Cogent Biosciences, Inc. (COGT) vs PTC Therapeutics, Inc. (PTCT)
- Cogent Biosciences, Inc. COGT 29.52 +0.03%
- PTC Therapeutics, Inc. PTCT 59.24 −2.87%
Cogent Biosciences, Inc. and PTC Therapeutics, Inc. are both Biotechnology companies. Cogent Biosciences, Inc. and PTC Therapeutics, Inc. are of similar size ($5.1B and $5.1B). Cogent Biosciences, Inc. grew revenue faster over the last twelve months: 110.2% against −42.8%. Cogent Biosciences, Inc. has the higher net margin (0.00% vs −3.80%) and the lower return on invested capital (0.00% vs 15.2%). Across the 17 metrics below, PTC Therapeutics, Inc. leads on 13 and Cogent Biosciences, Inc. on 4.
Valuation
Profitability
| Metric | COGT | PTCT | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 92.99% | 65.16% |
| Operating margin | 0.00% | 12.45% | 0.00% |
| Net margin | 0.00% | (3.80%) | 0.00% |
| Free cash flow margin | 0.00% | (29.76%) | 0.00% |
| Return on equity | (146.55%) | 20.64% | (56.36%) |
| Return on assets | (68.00%) | (1.30%) | (48.04%) |
| Return on invested capital | 0.00% | 15.16% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack